PHARMACOKINETICS AND PHARMACODYNAMICS OF GS-3583 IN CYNOMOLGUS MONKEYS

被引:1
|
作者
Kuhne, Michelle [1 ]
Chu, Hamlet [1 ]
Clarke, Christopher [1 ]
Carr, Brian [1 ]
Baca, Manuel [1 ]
Hung, Magdeleine [1 ]
Nagel, Mark [1 ]
Ambrogelly, Alexandre [1 ]
Rajakumaraswamy, Nishanathan [1 ]
机构
[1] Gilead Sci, San Francisco, CA USA
关键词
D O I
10.1136/jitc-2021-SITC2021.847
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
847
引用
收藏
页码:A888 / A888
页数:1
相关论文
共 50 条
  • [1] POPULATION PHARMACOKINETICS OF GS-3583 IN HEALTHY VOLUNTEERS AND PATIENTS WITH ADVANCED SOLID TUMORS
    Dauki, A.
    Jones, A.
    Singh, I.
    Rajakumaraswamy, N.
    Qin, A.
    Othman, A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S70 - S70
  • [2] EVALUATION OF THE SINGLE DOSE PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF GS-3583, A FLT3 AGONIST FC FUSION PROTEIN, IN A PHASE 1 STUDY IN HEALTHY VOLUNTEERS.
    Dauki, A.
    Rajakumaraswamy, N.
    Trowe, T.
    Singh, I.
    Vashishtha, A.
    Weng, W.
    Kuhne, M.
    Qin, A.
    Schwabe, C.
    Othman, A.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S18 - S18
  • [3] PHARMACODYNAMICS AND PHARMACOKINETICS OF SO-C101 IN CYNOMOLGUS MONKEYS
    Podzimkova, Nada
    Adkins, Irena
    de Martynoff, Guy
    Bechard, David
    Spisek, Radek
    Moebius, Ulrich
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A339 - A339
  • [4] Pharmacokinetics, pharmacodynamics, and safety of GS-3583, a FLT3 agonist Fc fusion protein, from single-ascending-dose phase I study in healthy participants
    Dauki, Anees M.
    Rajakumaraswamy, Nishanthan
    Trowe, Torsten
    Weng, Winnie
    Lin, Kai-Wen
    Elboudjwarej, Emon
    Qin, Ann Ran-Ran
    Schwabe, Christian
    Kuhne, Michelle R.
    Othman, Ahmed A.
    [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (08):
  • [5] Pharmacokinetics and Pharmacodynamics of Pegylated Interferon Lambda-1 in Cynomolgus Monkeys
    Byrnes-Blake, Kelly A.
    Pederson, Susan
    Klucher, Kevin M.
    Anderson-Haley, Monica
    Miller, Dennis M.
    Lopez-Talavera, Juan Carlos
    Freeman, Jeremy A.
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2012, 32 (05): : 198 - 206
  • [6] Pharmacokinetics and pharmacodynamics of a humanized monoclonal antibody to factor IX in cynomolgus monkeys
    Benincosa, LJ
    Chow, FS
    Tobia, LP
    Kwok, DC
    Davis, CB
    Jusko, WJ
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2000, 292 (02): : 810 - 816
  • [7] The pharmacokinetics and pharmacodynamics of OPG following single dose administration in cynomolgus monkeys.
    Martin, SW
    Sommers, JS
    Watson, AM
    Young, JD
    Dunstan, CR
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S399 - S399
  • [8] Pharmacodynamics of nateglinide and repaglinide in Cynomolgus monkeys
    Dunning, BE
    Gutierrez, C
    [J]. DIABETES, 1999, 48 : A104 - A104
  • [9] Pharmacokinetics and pharmacodynamics of CI-992 following intravenous and oral administration to cynomolgus monkeys
    Cook, JA
    Burger, PJ
    Michniewicz, BM
    Nordblom, GD
    Hicks, GW
    Kaplan, C
    Ryan, MJ
    [J]. BIOPHARMACEUTICS & DRUG DISPOSITION, 1998, 19 (03) : 185 - 191
  • [10] Pharmacokinetics of perfluorooctanoate in cynomolgus monkeys
    Butenhoff, JL
    Kennedy, GL
    Hinderliter, PM
    Lieder, PH
    Jung, R
    Hansen, KJ
    Gorman, GS
    Noker, PE
    Thomford, PJ
    [J]. TOXICOLOGICAL SCIENCES, 2004, 82 (02) : 394 - 406